SCHEMBL4728006

SCHEMBL4728006

Cc1ccccc1C(OCCN1CCN(C(c2ccccc2)c2ccccc2)CC1)c1ccccc1

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRNA7 P36544 1/20 0.77
MEN1 O00255 1/20 0.54
KMT2A Q03164 1/20 0.54
SIGMAR1 Q99720 3/20 0.54
CYP2D6 P10635 4/20 0.53
SLC6A2 P23975 3/20 0.53
SLC6A4 P31645 3/20 0.53
CYP2C19 P33261 3/20 0.53
SLC6A3 Q01959 3/20 0.53
CYP3A4 P08684 3/20 0.53
SLC22A1 O15245 2/20 0.53
CHRM2 P08172 2/20 0.53
ADRA2A P08913 2/20 0.53
CHRM1 P11229 2/20 0.53
DRD1 P21728 2/20 0.53
ADRA1A P35348 2/20 0.53
OPRM1 P35372 2/20 0.53
DRD3 P35462 2/20 0.53
KCNH2 Q12809 2/20 0.53
CYP2C9 P11712 2/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4667624 0.88 SIGMAR1 (0.68) MEN1KMT2ASIGMAR1CYP2D6SLC6A2
SCHEMBL8097776 0.84 CHRNA7 (0.79) CHRNA7MEN1KMT2ASIGMAR1CYP2D6
SCHEMBL10356303 0.81 SLC6A4 (0.70) MEN1KMT2ASIGMAR1CYP2D6SLC6A2
Hydrochloric Acid SCHEMBL10552395 0.80 SLC6A4 (0.68) MEN1KMT2ASIGMAR1CYP2D6SLC6A2
SCHEMBL10357800 0.79 SIGMAR1 (0.81) MEN1KMT2ASIGMAR1CYP2D6SLC6A2
SCHEMBL10552209 0.78 CHRNA7 (0.66) CHRNA7MEN1KMT2ASIGMAR1CYP2D6
SCHEMBL4667597 0.78 CYP2D6 (0.76) CHRNA7MEN1KMT2ACYP2D6SLC6A2
SCHEMBL7423150 0.78 CHRNA7 (0.65) CHRNA7MEN1KMT2ASIGMAR1CYP2D6
SCHEMBL7006203 0.78 TDP1 (0.60) MEN1KMT2ACYP2D6SLC6A2SLC6A4
SCHEMBL4667575 0.78 CYP2D6 (0.58) MEN1KMT2ASIGMAR1CYP2D6SLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1930308-A1 Pharmaceutical agents for the treatment of cerebral amyloidosis NYMOX CORPORATION (CA) 2008-06-11 EP disclosed
EP-1930308-A1 Pharmaceutical agents for the treatment of cerebral amyloidosis NYMOX CORPORATION (CA) 2008-06-11 EP disclosed
EP-0983222-B1 PHARMACEUTICAL AGENTS FOR THE TREATMENT OF CEREBRAL AMYLOIDOSIS NYMOX CORP (CA) 2007-11-28 EP disclosed
EP-0983222-B1 PHARMACEUTICAL AGENTS FOR THE TREATMENT OF CEREBRAL AMYLOIDOSIS NYMOX CORP (CA) 2007-11-28 EP disclosed